Pharmaceuticals and chemicals highlights to 15:40 BST |
|
|
|
Published
:
Wed, 04 Apr 2007 15:57
|
2007-04-04 14:22:32Bayer submits supplementary license application for leukemia drug Cambath to FDAFRANKFURT (AFX) - Bayer AG and Genzyme Corp have submitted a supplementarylicense application for the leukemia drug Campath to the US Food and DrugAdministration which will include first-line treatment for B-cell chroniclymphocytic leukemia (B-CLL).2007-04-04 14:05:00Chemtura to cut staff by 10 percentMIDDLEBURY, Conn. (AP) - Chemtura Corp., which makes industrial chemicals,pool, spa and home care products, said Wednesday it will cut 10 percent of itsstaff as part of a larger restructuring project designed to save $50 million ayear beginning in 2008.2007-04-04 13:46:20Monsanto 2Q earnings up 23 pct. to $543MST. LOUIS (AP) - Monsanto Co., which makes herbicides and geneticallymodified seeds, said Wednesday robust demand for its corn seeds and technologyfueled a 23 percent increase in second-quarter profit.2007-04-04 13:33:23Monsanto Q2 EPS beats market expectations; raises FY outlookST LOUIS (AFX) - Monsanto Co, the world's biggest biotech seed company,posted a second quarter profit that came in ahead of expectations, and raisedits guidance for the full year.2007-04-04 13:31:04Monsanto 2Q profit boosted by corn salesST. LOUIS (AP) - Monsanto Co., which makes herbicides and geneticallymodified seeds, on Wednesday said robust demand for its corn seeds andtechnology fueled a 23 percent increase in fiscal second-quarter profit.2007-04-04 13:22:20Hungary's TVK proposes no dividend; profit to be retained, earmarked for M&ABUDAPEST (AFX) - Chemical firm TVK Nyrt is proposing to pay no dividend toshareholders at its AGM on April 19.
|
|
|
|
Print this Story
Akzo Nobel ratings unchanged on planned biosciences sale, says S&P 